Arbuckle Stuart A bought VRTX

February 12, 2025 · Form 4 insider transaction

Arbuckle Stuart A bought 7,903 shares of Vertex Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
7,903
Price
$0.00
Total value
N/A
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2025
Filing dateFebruary 14, 2025
Shares owned after77,446
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Restricted stock unit award that vests in installments beginning on 02/24/2026.

View the original Form 4 on SEC EDGAR